Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month

Published:2024-01 Issue: Volume:170 Page:111266
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Chiu Sung-Hua,Lin Hsuan-Hwai,Feng An-Chieh,Lo Cheng-Hsiang,Hsieh Chung-Bao,Chen Pin-Ko,Chang Wei-Chou

Funder

National Science and Technology Council

Tri-Service General Hospital

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. Epidemiology of Hepatocellular Carcinoma;McGlynn;Hepatology,2021

2. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort);Trinchet;Hepatology,2015

3. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update;Reig;J Hepatol,2022

4. Current status of hepatocellular carcinoma in Japan;Ikeda;Chin. Clin. Oncol.,2013

5. Prognostic value of genotyping in hepatocellular carcinoma: A systematic review;Bodard;J Viral Hepat,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP